<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="review-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Vestnik dermatologii i venerologii</journal-id><journal-title-group><journal-title xml:lang="en">Vestnik dermatologii i venerologii</journal-title><trans-title-group xml:lang="ru"><trans-title>Вестник дерматологии и венерологии</trans-title></trans-title-group></journal-title-group><issn publication-format="print">0042-4609</issn><issn publication-format="electronic">2313-6294</issn><publisher><publisher-name xml:lang="en">Rossijskoe Obschestvo Dermatovenerologov i Kosmetologov</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">1330</article-id><article-id pub-id-type="doi">10.25208/vdv1330</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>REVIEWS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОБЗОР ЛИТЕРАТУРЫ</subject></subj-group><subj-group subj-group-type="article-type"><subject>Review Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">The role of cells of the innate immune system in psoriasis</article-title><trans-title-group xml:lang="ru"><trans-title>Роль клеток врожденной иммунной системы при псориазе</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1188-6578</contrib-id><contrib-id contrib-id-type="spin">1052-6474</contrib-id><name-alternatives><name xml:lang="en"><surname>Sorokina</surname><given-names>Ekaterina V.</given-names></name><name xml:lang="ru"><surname>Сорокина</surname><given-names>Екатерина Вячеславовна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>MD, Dr. Sci. (Med.)</p></bio><bio xml:lang="ru"><p>д.м.н.</p>
<p> </p></bio><email>sorokina-cathrine@yandex.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-8143-7356</contrib-id><contrib-id contrib-id-type="spin">9846-1006</contrib-id><name-alternatives><name xml:lang="en"><surname>Bisheva</surname><given-names>Irina V.</given-names></name><name xml:lang="ru"><surname>Бишева</surname><given-names>Ирина Васильевна</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>ibisheva@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">I.I. Mechnikov Research Institute for Vaccines and Sera</institution></aff><aff><institution xml:lang="ru">Научно-исследовательский институт вакцин и сывороток им. И.И. Мечникова</institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Federal Medical-Biological Agency of Russia</institution></aff><aff><institution xml:lang="ru">Академия постдипломного образования Федерального государственного бюджетного учреждения «Федеральный научно-клинический центр специализированных видов медицинской помощи и медицинских технологий Федерального медико-биологического агентства»</institution></aff></aff-alternatives><pub-date date-type="preprint" iso-8601-date="2022-11-01" publication-format="electronic"><day>01</day><month>11</month><year>2022</year></pub-date><pub-date date-type="pub" iso-8601-date="2022-11-23" publication-format="electronic"><day>23</day><month>11</month><year>2022</year></pub-date><volume>98</volume><issue>5</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>59</fpage><lpage>64</lpage><history><date date-type="received" iso-8601-date="2022-05-16"><day>16</day><month>05</month><year>2022</year></date><date date-type="accepted" iso-8601-date="2022-09-20"><day>20</day><month>09</month><year>2022</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2022, Sorokina E.V., Bisheva I.V.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2022, Сорокина Е.В., Бишева И.В.</copyright-statement><copyright-year>2022</copyright-year><copyright-holder xml:lang="en">Sorokina E.V., Bisheva I.V.</copyright-holder><copyright-holder xml:lang="ru">Сорокина Е.В., Бишева И.В.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://vestnikdv.ru/jour/article/view/1330">https://vestnikdv.ru/jour/article/view/1330</self-uri><abstract xml:lang="en"><p>Psoriasis is an immune-mediated disease with a complex pathogenesis. The close relationship between the development of psoriasis and the adaptive immune response is already known. However, recent data have shown that innate immune cells also play an important role in the development of psoriasis. Congenital lymphoid cells, dendritic cells, γδ T cells, NK cells, and NKT lymphocytes are activated in psoriasis, contributing to disease pathology through IL-17-dependent and independent mechanisms. During disease progression, γδ T cells secrete proinflammatory cytokines that induce and exacerbate the course of psoriasis. γδ T cells have memory cell properties that respond rapidly to secondary stimulation, which contributes to disease relapse. This article presents an overview of recent findings demonstrating the role of innate immunity in psoriasis.</p></abstract><trans-abstract xml:lang="ru"><p>Псориаз является иммуноопосредованным заболеванием со сложным патогенезом. Уже известна тесная взаимосвязь развития псориаза с адаптивным иммунным ответом. Однако последние данные показали, что клетки врожденного иммунитета также играют важную роль в развитии псориаза. Врожденные лимфоидные клетки, дендритные клетки, γδ Т-клетки, NK-клетки и NKT-лимфоциты активируются при псориазе, внося свой вклад в патологию заболевания посредством IL-17-зависимых и независимых механизмов. Во время развития заболевания γδ Т-клетки секретируют провоспалительные цитокины, которые индуцируют и усугубляют течение псориаза. γδ Т-клетки обладают свойствами клеток памяти, которые быстро реагируют на вторичную стимуляцию, что способствует рецидиву заболевания. В статье представлен обзор последних результатов, демонстрирующих роль врожденного иммунитета при псориазе.</p></trans-abstract><kwd-group xml:lang="en"><kwd>psoriasis</kwd><kwd>innate immunity</kwd><kwd>γδ T cells</kwd><kwd>NK cells</kwd><kwd>NKT lymphocytes</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>псориаз, врожденный иммунитет</kwd><kwd>γδ Т-клетки</kwd><kwd>NK-клетки</kwd><kwd>NKT-лимфоциты</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Keijsers RRMC, Joosten I, Erp PEJ van, Koenen HJPM, Kerkhof PCM van de. Cellular sources of IL-17 in psoriasis: a paradigm shift? Exp Dermatol. 2014;23(11):799–803. doi: 10.1111/exd.12487</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Hirota K, Ahlfors H, Duarte J, Stockinger B. Regulation and function of innate and adaptive interleukin-17-producing cells. EMBO Rep. 2012;13(2):113–120. doi: 10.1038/embor.2011.248</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Sato Y, Ogawa E, Okuyama R. Role of Innate Immune Cells in Psoriasis. Int J Mol Sci. 2020;21(18):6604. doi: 10.3390/ijms21186604</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Spits H, Artis D, Colonna M, Diefenbach A, Di Santo JP, Eberl G, Koyasu S, et al. Innate lymphoid cells-a proposal for uniform nomenclature. Nat Rev Immunol. 2013;13(2):145–149. doi: 10.1038/nri3365</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Diefenbach A, Colonna M, Koyasu S. Development, differentiation, and diversity of innate lymphoid cells. Immunity. 2014;41(3):354–365. doi: 10.1016/j.immuni.2014.09.005</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Teunissen M, Munneke J, Bernink JH, Spuls PI, Res PCM, Velde AT, et al. Composition of innate lymphoid cell subsets in the human skin: enrichment of NCR(+) ILC3 in lesional skin and blood of psoriasis patients. J Invest Dermatol. 2014;134(9):2351–2360. doi: 10.1038/jid.2014.146</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Villanova F, Flutter B, Tosi I, Grys K, Sreeneebus H, Perera G, et al. Characterization of innate lymphoid cells in human skin and blood demonstrates increase of NKp44+ ILC3 in psoriasis. J Invest Dermatol. 2014;134(4):984–991. doi: 10.1038/jid.2013.477</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Brennan PJ, Brigl M, Brenner MB. Invariant natural killer T cells: an innate activation scheme linked to diverse effector functions. Nat Rev Immunol. 2013;13(2):101–117. doi: 10.1038/nri3369</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Bonish B, Jullien D, Dutronc Y, Huang BB, Modlin R, Spada FM, et al. Overexpression of CD1d-dependent INF-γ production by NK-T cells. J Immunol. 2000;165(7):4076–4085. doi: 10.4049/jimmunol.165.7.4076</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Vissers WHPM, Berends M, Muys L, Erp PEJ van, Jong EMGJ de, Kerkhof PCM van de. The effect of the combination of calcipotriol and betamethasone dipropionate versus both monotherapies on epidermal proliferation, keratinization and T-cell subsets in chronic plaque psoriasis. Exp Dermatol. 2004;13(2):106–112. doi: 10.1111/j.0906-6705.2004.00151.x</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Bovenschen HJ, Gerritsen WJ, Rens DWA van, Seyger MMB, Jong EMGJ de, Kerkhof PCM van de. Explorative immunohistochemical study to evaluate the addition of a topical corticosteroid in the early phase of alefacept treatment for psoriasis. Arch Dermatol Res. 2007;298(9):457–463. doi: 10.1007/s00403-006-0716-7</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Coquet JM, Chakravarti S, Kyparissoudis K, McNab FW, Pitt LA, McKenzie BS, et al. Diverse cytokine production by NKT cell subsets and identification of an IL-17-producing CD4-NK1.1-NKT cell population. Proc Natl Acad Sci USA. 2008;105(12):11287–11292. doi: 10.1073/pnas.0801631105</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Doisne JM, Soulard V, Bécourt C, Amniai L, Henrot P, Havenar-Daughton C, et al. Cutting edge: сrucial role of IL-1 and IL-23 in the innate IL-17 response of peripheral lymph node NK1.1- invariant NKT cells to bacteria. J Immunol. 2011;186(2):662–666. doi: 10.4049/jimmunol.1002725</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Doisne JM, Becourt C, Amniai L, Duarte N, Le Luduec JB, Eberl G, et al. Skin and peripheral lymph nodeiInvariant NKT cells are mainly retinoic acid receptor-related orphan receptor γt+ and respond preferentially under inflammatory conditions. J Immunol. 2009;183(3): 2142–2149. doi: 10.4049/jimmunol.0901059</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Webster KE, Kim HO, Kyparissoudis K, Corpuz TM, Pinget GV, Uldrich AP, et al. IL-17-producing NKT cells depend exclusively on IL-7 for homeostasis and survival. Mucosal Immunol. 2014;7(5):1058–1067. doi: 10.1038/mi.2013.122</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Milosavljevic N, Gazdic M, Markovic BS, Arsenijevic A, Nurkovic J, Dolicanin Z, et al. Mesenchymal stem cells attenuate acute liver injury by altering ratio between interleukin 17 producing and regulatory natural killer T cells. Liver Transpl. 2017;23(8):1040–1050. doi: 10.1002 / lt.24784</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Cameron AL, Kirby B, Fei W, Griffiths CEM. Natural killer and natural killer-T cells in psoriasis. Arch Dermatol Res. 2002;294(8):363–369. doi: 10.1007/s00403-002-0349-4</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Vissers WHPM, Arndtz CHM, Muys L, Erp PEJ van, Jong EMG de, Kerkhof PCM van de. Memory effector (CD45RO+) and cytotoxic (CD8+) T cells appear early in the margin zone of spreading psoriatic lesions in contrast to cells expressing natural killer receptors, which appear late. Br J Dermatol. 2004;150(5):852–859. doi: 10.1111/j.1365-2133.2004.05683.x</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Ottaviani C, Nasorri F, Bedini C, Pità O de, Girolomoni G, Cavani A. CD56brightCD16(-) NK cells accumulate in psoriatic skin in response to CXCL10 and CCL5 and exacerbate skin inflammation. Eur J Immunol. 2006;36(1):118–128. doi: 10.1002/eji.200535243</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Cameron AL, Kirby B, Griffiths CEM. Circulating natural killer cells in psoriasis. Br J Dermatol. 2003;149(1):160–164. doi: 10.1046/j.1365-2133.2003.05319.x</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Gambichler T, Zhang Y, Höxtermann S, Kreuter A. Natural killer cells and B lymphocytes in peripheral blood of patients with psoriasis. Br J Dermatol. 2013;168(4):894–896. doi: 10.1111/bjd.12067</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Chowdhury AC, Chaurasia S, Mishra SK, Aggarwal A, Misra R. IL-17 and IFN-γ producing NK and γδ T cells are preferentially expanded in synovial fluid of patients with reactive arthritis and undifferentiated spondyloarthritis. Clin Immunol. 2017;183:207–212. doi: 10.1016/j.clim.2017.03.016</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Surcel M, Munteanu AN, Huică RI, Isvoranu G, Pîrvu IR, Constantin C, et al. Reinforcing involvement of NK cells in psoriasiform dermatitis animal model. Exp Ther Med. 2019;18(6):4956–4966. doi: 10.3892/etm.2019.7967</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Schiavoni G, Mattei F, Sestili P, Borghi P, Venditti M, Morse HC, et al. ICSBP is essential for the development of mouse type I interferon-producing cells and for the generation and activation of CD8γ(+) dendritic cells. J Exp Med 2002;196(11):1415–1425. doi: 10.1084/jem.20021263</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Zaba LC, Fuentes-Duculan J, Eungdamrong NJ, Abello MV, Novitskaya I, Pierson KC, et al. Psoriasis is characterized by accumulation of immunostimulatory and Th1/Th17 cell-polarizing myeloid dendritic cells. J Invest Dermatol. 2009;129(1):79–88. doi: 10.1038/jid.2008.194</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Zaba LC, Cardinale I, Gilleaudeau P, Sullivan-Whalen M, Suárez-Fariñas M, Fuentes-Duculan J, et al. Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses. J Exp Med. 2007;204(13):3183–3194. doi: 10.1084/jem.20071094</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Singh TP, Zhang HH, Borek I, Wolf P, Hedrick MN, Singh SP, et al. Monocyte-derived inflammatory Langerhans cells and dermal dendritic cells mediate psoriasis-like inflammation. Nat Commun. 2016;7:13581. doi: 10.1038/ncomms13581</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Brunner PM, Koszik F, Reininger B, Kalb ML, Bauer W, Stingl G. Infliximab induces downregulation of the IL-12/IL-23 axis in 6-sulfo-LacNac (slan)+ dendritic cells and macrophages. J Allergy Clin Immunol. 2013;132(5):1184-1193. doi: 10.1016/j.jaci.2013.05.036</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Jariwala SP. The role of dendritic cells in the immunopathogenesis of psoriasis. Arch Dermatol Res. 2007;299(8):359–366. doi: 10.1007/s00403-007-0775-4</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Bonneville M, O’Brien RL, Born WK. γδ-T cell effector functions: a blend of innate programming and acquired plasticity. Nat Rev Immunol. 2010;10(7):467–478. doi: 10. 1038/nri2781</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Cai Y, Xue F, Fleming C, Yang J, Ding C, Ma Y, et al. Differential developmental requirement and peripheral regulation for dermal Vγ4 and Vγ6T17 cells in health and inflammation. Nat Commun. 2014;5:3986. doi: 10.1038/ncomms 4986</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Mabuchi T, Takekoshi T, Hwang ST. Epidermal CCR6+ γδ T cells are major producers of IL-22 and IL-17 in a murine model of psoriasiform dermatitis. J Immunol. 2011;187(10):5026–5031. doi: 10.4049/jimmunol.1101817</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Witherden DA, Johnson MD, Havran WL. Coreceptors and their ligands in epithelial γδ T cell biology. Front Immunol. 2018;9:731. doi: 10.3389/fimmu.2018.00731</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Cai Y, Shen X, Ding C, Qi C, Li K, Li X, et al. Pivotal role of dermal IL-17-producing γδ T cells in skin inflammation. Immunity. 2011;35(4):596–610. doi: 10.1016/j.immuni.2011.08.001</mixed-citation></ref></ref-list></back></article>
